• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

科兴疫苗诱导的促进Fc介导的中性粒细胞吞噬作用的抗体与COVID-19疾病的缓解相关。

CoronaVac-induced antibodies that facilitate Fc-mediated neutrophil phagocytosis track with COVID-19 disease resolution.

作者信息

Li Chuang, Yu Jie, Issa Rahma, Wang Lili, Ning Mingzhe, Yin Shengxia, Li Jie, Wu Chao, Chen Yuxin

机构信息

Department of Laboratory Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.

Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, People's Republic of China.

出版信息

Emerg Microbes Infect. 2025 Dec;14(1):2434567. doi: 10.1080/22221751.2024.2434567. Epub 2025 Jan 13.

DOI:10.1080/22221751.2024.2434567
PMID:39584817
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11731273/
Abstract

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants raise concerns about decreased vaccine efficacy, vaccines continue to confer robust protection in humans, implying that immunity beyond neutralization contributes to vaccine efficacy. In addition to neutralization, antibodies can mediate various Fc-dependent effector functions, including antibody-dependent cellular phagocytosis (ADCP), antibody-dependent neutrophil phagocytosis (ADNP) and antibody-dependent cellular cytotoxicity (ADCC). However, the specific role of each Fc-mediated effector function in contributing to COVID-19 disease attenuation in human remains unclear. To fully define the potential immune correlates of Fc-mediated effector functions, we comprehensively analysed the above Fc-mediated effector functions in two study cohorts. In the CoronaVac vaccinee cohort, individuals without breakthrough infection exhibited higher levels of ADCP and ADNP activities with a greater degree of cross-reactivity compared to those who had breakthrough infection. A predictive model was established incorporating ADNP activity and IgG titre, achieving an area under the curve (AUC) of 0.837. In the COVID-19 patient cohort, BA.5-specific ADCP and ADNP responses were significantly reduced in COVID-19 patients with fatal outcomes compared to milder outcomes. The prognostic model incorporating WT, BA.5, and XBB.1.5 spike-specific ADNP demonstrated effective predictive ability, achieving an AUC of 0.890. Meanwhile, transcriptomic analysis of peripheral blood mononuclear cells (PBMCs) from COVID-19 patients in the acute phases of infection highlighted remarkably upregulation of neutrophil activity and phagocytic function, further reinforcing the essential role of ADNP. Collectively, our findings underscored Fc-mediated effector activities, especially neutrophil phagocytosis, as significant antibody biomarkers for the risk of SARS-CoV-2 breakthrough infection and COVID-19 prognosis.

摘要

尽管严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变种引发了对疫苗效力下降的担忧,但疫苗在人类中仍能提供强大的保护,这意味着中和作用之外的免疫力有助于疫苗效力。除中和作用外,抗体还可介导多种Fc依赖性效应功能,包括抗体依赖性细胞吞噬作用(ADCP)、抗体依赖性中性粒细胞吞噬作用(ADNP)和抗体依赖性细胞毒性(ADCC)。然而,每种Fc介导的效应功能在减轻人类COVID-19疾病方面的具体作用仍不清楚。为了全面定义Fc介导的效应功能的潜在免疫相关性,我们在两个研究队列中全面分析了上述Fc介导的效应功能。在科兴疫苗接种者队列中,与发生突破性感染的个体相比,未发生突破性感染的个体表现出更高水平的ADCP和ADNP活性,且交叉反应程度更高。建立了一个纳入ADNP活性和IgG滴度的预测模型,曲线下面积(AUC)为0.837。在COVID-19患者队列中,与症状较轻的患者相比,出现致命结果的COVID-19患者中BA.5特异性ADCP和ADNP反应显著降低。纳入野生型、BA.5和XBB.1.5刺突特异性ADNP的预后模型显示出有效的预测能力,AUC为0.890。同时,对感染急性期COVID-19患者外周血单个核细胞(PBMC)的转录组分析突出显示中性粒细胞活性和吞噬功能显著上调,进一步强化了ADNP的重要作用。总体而言,我们的研究结果强调了Fc介导的效应活性,尤其是中性粒细胞吞噬作用,是SARS-CoV-2突破性感染风险和COVID-19预后的重要抗体生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a785/11731273/950b65080646/TEMI_A_2434567_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a785/11731273/942d9c28b917/TEMI_A_2434567_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a785/11731273/a0925c2398f3/TEMI_A_2434567_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a785/11731273/c530537aa4b3/TEMI_A_2434567_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a785/11731273/ee0fbff179dd/TEMI_A_2434567_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a785/11731273/a01c267925c5/TEMI_A_2434567_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a785/11731273/950b65080646/TEMI_A_2434567_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a785/11731273/942d9c28b917/TEMI_A_2434567_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a785/11731273/a0925c2398f3/TEMI_A_2434567_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a785/11731273/c530537aa4b3/TEMI_A_2434567_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a785/11731273/ee0fbff179dd/TEMI_A_2434567_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a785/11731273/a01c267925c5/TEMI_A_2434567_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a785/11731273/950b65080646/TEMI_A_2434567_F0006_OC.jpg

相似文献

1
CoronaVac-induced antibodies that facilitate Fc-mediated neutrophil phagocytosis track with COVID-19 disease resolution.科兴疫苗诱导的促进Fc介导的中性粒细胞吞噬作用的抗体与COVID-19疾病的缓解相关。
Emerg Microbes Infect. 2025 Dec;14(1):2434567. doi: 10.1080/22221751.2024.2434567. Epub 2025 Jan 13.
2
Coronavac inactivated vaccine triggers durable, cross-reactive Fc-mediated phagocytosis activities.科兴中维新冠病毒灭活疫苗可诱导持久、交叉反应的 Fc 介导的吞噬作用。
Emerg Microbes Infect. 2023 Dec;12(2):2225640. doi: 10.1080/22221751.2023.2225640.
3
COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.COVID-19 严重程度与抗体 Fc 介导的固有免疫功能的差异有关。
mBio. 2021 Apr 20;12(2):e00281-21. doi: 10.1128/mBio.00281-21.
4
Dose-dependent serological profiling of AdCLD-CoV19-1 vaccine in adults.成人中AdCLD-CoV19-1疫苗的剂量依赖性血清学分析
mSphere. 2025 Jan 28;10(1):e0099824. doi: 10.1128/msphere.00998-24. Epub 2024 Dec 26.
5
Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins.抗严重急性呼吸综合征冠状病毒 2 超免疫球蛋白通过 N 和 S 蛋白显示出强大的中和作用以及抗体依赖的细胞细胞毒性和吞噬作用。
J Infect Dis. 2022 Mar 15;225(6):938-946. doi: 10.1093/infdis/jiab540.
6
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.SARS-CoV-2 BA.4/5 感染在混合免疫背景下比 BA.1 引发更多的交叉反应性 FcγRIIIa 信号传导和中和作用。
J Virol. 2024 Jul 23;98(7):e0067824. doi: 10.1128/jvi.00678-24. Epub 2024 Jul 2.
7
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma.恢复期血浆中 SARS-CoV-2 多功能抗体的标志物。
mBio. 2021 Apr 20;12(2):e00765-21. doi: 10.1128/mBio.00765-21.
8
Deciphering Fc-effector functions against SARS-CoV-2.解析针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的Fc效应器功能。
Trends Microbiol. 2024 Aug;32(8):756-768. doi: 10.1016/j.tim.2024.01.005. Epub 2024 Feb 15.
9
Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities.异源 Ad26/Ad5 腺病毒载体疫苗诱导产生了具有强大 Fc 活性的 SARS-CoV-2 特异性抗体反应。
Front Immunol. 2024 May 8;15:1382619. doi: 10.3389/fimmu.2024.1382619. eCollection 2024.
10
Neutrophils mediate HIV-specific antibody-dependent phagocytosis and ADCC.中性粒细胞介导HIV特异性抗体依赖性吞噬作用和抗体依赖的细胞介导的细胞毒性作用。
J Immunol Methods. 2018 Jun;457:41-52. doi: 10.1016/j.jim.2018.03.007. Epub 2018 Mar 29.

引用本文的文献

1
Immune Biomarkers, Profiles, and Responses: A Vaccine Ontology Perspective.免疫生物标志物、特征与反应:疫苗本体论视角
bioRxiv. 2025 Jul 22:2025.07.18.665557. doi: 10.1101/2025.07.18.665557.
2
Evaluation of broad-spectrum protection by novel mRNA vaccines against SARS-CoV-2 variants (Delta, Omicron-BA.5, XBB-EG.5) in the golden hamster model.在金黄仓鼠模型中评估新型mRNA疫苗对SARS-CoV-2变体(德尔塔、奥密克戎-BA.5、XBB-EG.5)的广谱保护作用。
Virol J. 2025 May 24;22(1):159. doi: 10.1186/s12985-025-02787-7.
3
A Hidden Guardian: The Stability and Spectrum of Antibody-Dependent Cell-Mediated Cytotoxicity in COVID-19 Response in Chinese Adults.

本文引用的文献

1
Protective non-neutralizing SARS-CoV-2 monoclonal antibodies.保护性非中和性 SARS-CoV-2 单克隆抗体。
Trends Immunol. 2024 Aug;45(8):609-624. doi: 10.1016/j.it.2024.06.003. Epub 2024 Jul 20.
2
SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients.奥密克戎变异株感染增强了三剂科兴疫苗接种者的全身性和黏膜免疫的幅度和持久性。
mBio. 2024 Apr 10;15(4):e0240723. doi: 10.1128/mbio.02407-23. Epub 2024 Mar 8.
3
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19.
一位隐藏的守护者:中国成年人新冠病毒感染反应中抗体依赖的细胞介导细胞毒性作用的稳定性及范围
Vaccines (Basel). 2025 Feb 28;13(3):262. doi: 10.3390/vaccines13030262.
ChAdOx1 nCoV-19(AZD1222)疫苗诱导的 Fc 受体结合与对 COVID-19 的不同易感性相关。
Nat Immunol. 2023 Jul;24(7):1161-1172. doi: 10.1038/s41590-023-01513-1. Epub 2023 Jun 15.
4
Coronavac inactivated vaccine triggers durable, cross-reactive Fc-mediated phagocytosis activities.科兴中维新冠病毒灭活疫苗可诱导持久、交叉反应的 Fc 介导的吞噬作用。
Emerg Microbes Infect. 2023 Dec;12(2):2225640. doi: 10.1080/22221751.2023.2225640.
5
Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates.mRNA-1273 和 Novavax 原始或 BA.1 刺突增强疫苗对非人类灵长类动物 SARS-CoV-2 BA.5 感染的疗效。
Sci Immunol. 2023 Oct 27;8(88):eadg7015. doi: 10.1126/sciimmunol.adg7015.
6
Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates.针对埃博拉病毒可溶性糖蛋白的抗体与非人类灵长类动物的长期疫苗介导保护有关。
Cell Rep. 2023 Apr 25;42(4):112402. doi: 10.1016/j.celrep.2023.112402. Epub 2023 Apr 15.
7
T Cell Responses to SARS-CoV-2.T细胞对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的反应。
Annu Rev Immunol. 2023 Apr 26;41:343-373. doi: 10.1146/annurev-immunol-101721-061120. Epub 2023 Feb 7.
8
A longitudinal study of humoral immune responses induced by a 3-dose inactivated COVID-19 vaccine in an observational, prospective cohort.一项关于三剂灭活新冠疫苗在观察性前瞻性队列中诱导的体液免疫反应的纵向研究。
BMC Immunol. 2022 Nov 16;23(1):57. doi: 10.1186/s12865-022-00532-1.
9
Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.接种 BNT162b2、mRNA-1273 和 Ad26.COV2.S 疫苗后 COVID-19 重症发病情况。
JAMA. 2022 Oct 11;328(14):1427-1437. doi: 10.1001/jama.2022.17985.
10
Effectiveness of mRNA COVID-19 vaccines against Omicron and Delta variants in a matched test-negative case-control study among US veterans.mRNA COVID-19 疫苗在一项美国退伍军人配对病例对照研究中对奥密克戎和德尔塔变异株的有效性。
BMJ Open. 2022 Aug 3;12(8):e063935. doi: 10.1136/bmjopen-2022-063935.